Gilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial, found 100% effective
Gilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial, found 100% effective
www.cnbc.com Gilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial
Gilead's experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial, the company said Thursday.
![Gilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial](https://lemmy.world/pictrs/image/dd3ff9ee-6d07-4c51-b284-aac277431deb.jpeg?format=webp&thumbnail=256)
4
crossposts
2
comments
Unfortunate corporate name.
1 0 ReplyUnder His Eye
1 0 Reply